What’s Next for Pharma?

Drug pricing, innovation, and the next frontier of integrated pharmaceutical portfolios.

Redesigned at the right time, with the right people, through transformational partnerships.

What’s Next for Pharma: Newsletter & Consulting Consortium

The only newsletter to link the Indian pharmaceutical market with the global US-EU-India-China-Japan Axis of the pharmaceutical & biotechnology industry. Head over to our Newsletter home to learn more, & subscribe.

A Win-for-all Negotiation to the MFN times, drug pricing, & tariffs

From silos to integrated think-tanks, more on the central theme of What's Next for Pharma

What’s Next for Pharma combines people leadership, scientific expertise, and insight, along with AI-driven integration of these insights to build connected, quick, and accessible outcomes for the bio-pharmaceutical landscape.

We offer these integrated insights through our newsletter, as well as through our consulting vertical. A unique newsletter model that gives subscribers the opportunity to run their own platform gives us the ability to build connectivity through their contributed insight.

A unique consulting model that combines strategic frameworks, insights from Biopharma leadership, & AI-driven integration of these insights, helps us build connectivity and quick outcomes.

For more on What’s Next for Pharma & what we do, head over to our Newsletter & What We Offer page, where you'll find subscription models to our newsletter, & more on our program management consulting services.

Head over to the Times of India & Forbes India to read more about our recent ideas surrounding stabilizing global innovation markets & pharmaceutical pipelines. We are always looking to spark conversation & collaboration regarding the pressing topics of innovation, drug pricing, & trade, in & outside of the pharmaceutical industry.